Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Pediatric Xiao Chai Hu granules (Xiao'er Chaihu Keli) is a Traditional Chinese Medicine (TCM) botanical product developed by Guangzhou Baiyunshan Guanghua Pharmaceutical. It is derived from the classic Xiao Chai Hu Tang formula, which is traditionally used to harmonize the Shaoyang stage in TCM theory. The preparation is specifically formulated for pediatric use to treat gastrointestinal-type common colds and upper respiratory tract infections characterized by Shaoyang syndrome, with symptoms such as alternating chills and fever, chest fullness, and digestive upset. It is currently undergoing Phase II clinical evaluation in China (CTR20253842) to assess its efficacy and safety in children.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Pediatric Xiao Chai Hu granules.